Literature DB >> 16816951

Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?

S Brugman1, F A Klatter, J T J Visser, A C M Wildeboer-Veloo, H J M Harmsen, J Rozing, N A Bos.   

Abstract

AIMS/HYPOTHESIS: Accumulating data suggest that the gut immune system plays a role in the development of type 1 diabetes. The intestinal flora is essential for the development of the (gut) immune system and the establishment of tolerance. It has been reported that oral administration of food and bacterial antigens early in life suppresses later development of diabetes in the Bio-Breeding diabetes-prone (BB-DP) rat. This study was designed to investigate the possible relationship between the development of diabetes and the composition of intestinal flora.
MATERIALS AND METHODS: The intestinal flora of BB-DP rats, a rat model for type 1 diabetes, was characterised long before the clinical onset of diabetes by fluorescent in situ hybridisation. In a separate experiment, BB-DP rats were treated with antibiotics and the effect on diabetes incidence and level of insulitis was analysed.
RESULTS: We observed a difference in bacterial composition between rats that eventually did and those that did not develop diabetes. This difference was detectable long before clinical onset of the disease. Rats that did not develop diabetes at a later age displayed a lower amount of Bacteroides sp. Modulation of the intestinal flora through antibiotic treatment decreased the incidence and delayed the onset of diabetes. A combination of antibiotic treatment and a protective hydrolysed casein diet completely prevented diabetes in the BB-DP rat. CONCLUSIONS/
INTERPRETATION: Our data suggest that the intestinal flora is involved in the development of type 1 diabetes. Factors influencing composition of the intestinal flora could be a target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816951     DOI: 10.1007/s00125-006-0334-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Gluten-free diet prevents diabetes in NOD mice.

Authors:  D P Funda; A Kaas; T Bock; H Tlaskalová-Hogenová; K Buschard
Journal:  Diabetes Metab Res Rev       Date:  1999 Sep-Oct       Impact factor: 4.876

2.  Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells.

Authors:  Laurens A van der Waaij; H J M Harmsen; M Madjipour; F G M Kroese; M Zwiers; H M van Dullemen; N K de Boer; G W Welling; P L M Jansen
Journal:  Inflamm Bowel Dis       Date:  2005-10       Impact factor: 5.325

Review 3.  Food-induced type 1 diabetes in the BB rat.

Authors:  F W Scott
Journal:  Diabetes Metab Rev       Date:  1996-12

4.  Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines.

Authors:  H Kolb; U Wörz-Pagenstert; R Kleemann; H Rothe; P Rowsell; F W Scott
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

5.  Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria.

Authors:  Nita H Salzman; Hendrik de Jong; Yvonne Paterson; Hermie J M Harmsen; Gjalt W Welling; Nicolaas A Bos
Journal:  Microbiology       Date:  2002-11       Impact factor: 2.777

6.  Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats.

Authors:  K Bendtzen; M Diamant; T Horn; C Pedersen; K Buschard
Journal:  J Endocrinol       Date:  1992-03       Impact factor: 4.286

7.  Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice.

Authors:  Axel Kornerup Hansen; Fengjun Ling; Anne Kaas; David P Funda; Helene Farlov; Karsten Buschard
Journal:  Diabetes Metab Res Rev       Date:  2006 May-Jun       Impact factor: 4.876

8.  Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.

Authors:  F W Scott; H E Cloutier; R Kleemann; U Wöerz-Pagenstert; P Rowsell; H W Modler; H Kolb
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

9.  Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against Type 1 diabetes in BB-DP rats. An experimental study.

Authors:  S Brugman; F A Klatter; J Visser; N A Bos; D Elias; J Rozing
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

10.  Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats.

Authors:  K Buschard; C Pedersen; S V Hansen; I Hageman; K Aaen; K Bendtzen
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

  10 in total
  135 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

2.  Diabetes-related alterations in the enteric nervous system and its microenvironment.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Diabetes       Date:  2012-05-15

3.  Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice.

Authors:  Camilla H F Hansen; Christian S Larsen; Henriette O Petersson; Line F Zachariassen; Andreas Vegge; Charlotte Lauridsen; Witold Kot; Łukasz Krych; Dennis S Nielsen; Axel K Hansen
Journal:  Diabetologia       Date:  2019-05-28       Impact factor: 10.122

4.  Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108.

Authors:  R F Schwartz; J Neu; D Schatz; M A Atkinson; C Wasserfall
Journal:  Diabetologia       Date:  2006-11-21       Impact factor: 10.122

Review 5.  Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.

Authors:  Volker Mai; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

6.  Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes.

Authors:  Chiara Sorini; Marika Falcone
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

7.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 8.  The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

9.  Aberrant gut microbiota composition at the onset of type 1 diabetes in young children.

Authors:  Marcus C de Goffau; Susana Fuentes; Bartholomeus van den Bogert; Hanna Honkanen; Willem M de Vos; Gjalt W Welling; Heikki Hyöty; Hermie J M Harmsen
Journal:  Diabetologia       Date:  2014-06-15       Impact factor: 10.122

10.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.